T. MORIE

459 total citations
33 papers, 346 citations indexed

About

T. MORIE is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, T. MORIE has authored 33 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 14 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in T. MORIE's work include Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Chemical Synthesis and Analysis (4 papers). T. MORIE is often cited by papers focused on Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (6 papers) and Chemical Synthesis and Analysis (4 papers). T. MORIE collaborates with scholars based in Japan and United States. T. MORIE's co-authors include Shiro Kato, Naoyuki Yoshida, Hiroshi Harada, Junichi Matsumoto, Yoshimi Hirokawa, Hiroshi Harada, Tatsuya Kon, Tadahiko Karasawa, Iwao Fujiwara and T. YOSHIDA and has published in prestigious journals such as Journal of Medicinal Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Tetrahedron.

In The Last Decade

T. MORIE

31 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. MORIE Japan	12	240	159	37	26	22	33	346
Jacob J. Plattner United States	10	171 0.7×	173 1.1×	16 0.4×	37 1.4×	11 0.5×	11	347
Satoshi Tamai Japan	13	302 1.3×	172 1.1×	25 0.7×	77 3.0×	6 0.3×	32	453
Richard A. Haack United States	8	199 0.8×	104 0.7×	20 0.5×	39 1.5×	8 0.4×	22	318
Richard A. Price United Kingdom	9	124 0.5×	142 0.9×	21 0.6×	19 0.7×	8 0.4×	16	311
Madhup K. Dhaon United States	9	189 0.8×	226 1.4×	40 1.1×	25 1.0×	17 0.8×	14	345
Weixu Zhai United States	13	227 0.9×	230 1.4×	34 0.9×	44 1.7×	72 3.3×	25	450
Harry J. Wadsworth United Kingdom	8	295 1.2×	190 1.2×	31 0.8×	32 1.2×	29 1.3×	20	446
Martin Kratzel Austria	11	138 0.6×	176 1.1×	47 1.3×	14 0.5×	15 0.7×	31	399
Kang Man Lee South Korea	12	168 0.7×	246 1.5×	15 0.4×	17 0.7×	30 1.4×	31	429
Jean-Claude Ziegler France	7	211 0.9×	251 1.6×	23 0.6×	29 1.1×	14 0.6×	10	337

Countries citing papers authored by T. MORIE

Since Specialization

Citations

This map shows the geographic impact of T. MORIE's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. MORIE with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. MORIE more than expected).

Fields of papers citing papers by T. MORIE

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. MORIE. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. MORIE. The network helps show where T. MORIE may publish in the future.

Co-authorship network of co-authors of T. MORIE

This figure shows the co-authorship network connecting the top 25 collaborators of T. MORIE. A scholar is included among the top collaborators of T. MORIE based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. MORIE. T. MORIE is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Honda, Yayoi, et al.. (2005). A Novel αvβ3 Integrin Antagonist Suppresses Neointima Formation for More Than 4 Weeks After Balloon Injury in Rats. Arteriosclerosis Thrombosis and Vascular Biology. 25(7). 1376–1382. 8 indexed citations

Kitano, Tomoko, et al.. (2004). Discovery of a potent and selective αvβ3 integrin antagonist with strong inhibitory activity against neointima formation in rat balloon injury model. Bioorganic & Medicinal Chemistry Letters. 14(10). 2567–2570. 11 indexed citations

Kitano, Tomoko, et al.. (2004). Discovery of a Potent and Selective α_vβ₃ Integrin Antagonist with Strong Inhibitory Activity Against Neointima Formation in Rat Balloon Injury Model.. ChemInform. 35(39). 1 indexed citations

Kato, Shiro, T. MORIE, Iwao Fujiwara, & Naoyuki Yoshida. (1998). Nitrogen-containing Heteroalicycles with Serotonin 5-HT3 and 5-HT4 Receptor Binding Affinities. Development of Gastroprokinetic and Antiemetic Agents.. Journal of Synthetic Organic Chemistry Japan. 56(10). 851–862.

Hirokawa, Yoshimi, T. MORIE, Hiroshi Yamazaki, Naoyuki Yoshida, & Shiro Kato. (1998). A novel series of N-(hexahydr-1,4-diazepin-6-yl) and N-(hexahydroazepin-3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors. Bioorganic & Medicinal Chemistry Letters. 8(6). 619–624. 11 indexed citations

Nakamura, Kazuhiko, T. MORIE, & Shiro Kato. (1998). New Approach to (3R,4R)-3-Amino-N-benzyloxycarbonyl-4-hydroxy-hexahydro-1H-azepine Using Ring Expansion of Optically Active Piperidine Derivative. Heterocycles. 48(3). 427–427. 14 indexed citations

MORIE, T., Hiroshi Harada, & Shiro Kato. (1997). Convenient Synthesis ofN-(2, 2-Dimethyl-1, 3-dioxan-5-yl)-1H-indazole-3-carboxamide, the Intermediate of 5-HT₃Receptor Antagonist. Synthetic Communications. 27(4). 559–566. 9 indexed citations

Kato, Shiro, T. MORIE, & Naoyuki Yoshida. (1996). Synthesis and Biological Activity of 4-Amino-5-chloro-2-ethoxy-3-hydroxybenzamides, Metabolites of a New Gastroprokinetic Agent, Mosapride.. Chemical and Pharmaceutical Bulletin. 44(8). 1484–1492. 3 indexed citations

Harada, Hiroshi, T. MORIE, Yoshimi Hirokawa, & Shiro Kato. (1996). An Efficient Synthesis of 6-Substituted Aminohexahydro-1H-1,4-diazepines from 2-Substituted Aminopropenals.. Chemical and Pharmaceutical Bulletin. 44(12). 2205–2212. 19 indexed citations

10.

Kato, Shiro, T. MORIE, & Naoyuki Yoshida. (1995). Synthesis and Biological Activities of Metabolites of Mosapride, a New Gastroprokinetic Agent.. Chemical and Pharmaceutical Bulletin. 43(4). 699–702. 18 indexed citations

11.

Harada, Hiroshi, T. MORIE, Yoshimi Hirokawa, et al.. (1995). Development of Potent Serotonin-3 (5-HT3) Receptor Antagonists. II. Structure-Activity Relationships of N-(1-Benzyl-4-methylhexahydro-lH-1,4-diazepin-6-yl)carboxamides.. Chemical and Pharmaceutical Bulletin. 43(11). 1912–1930. 27 indexed citations

12.

MORIE, T., et al.. (1995). Synthesis and Structure-Activity Relationships of 4-Amino-5-chloro-2-ethoxybenzamides with Six- and Seven-Membered Heteroalicycles as Potential Gastroprokinetic Agents.. Chemical and Pharmaceutical Bulletin. 43(7). 1137–1147. 5 indexed citations

13.

Harada, Hiroshi, T. MORIE, Yoshitsugu Hirokawa, Naoyuki Yoshida, & Shiro Kato. (1995). Development of Potent Serotonin-3 (5-HT3) Receptor Antagonists. I. Structure-Activity Relationships of 2-Alkoxy-4-amino-5-chlorobenzamide Derivatives.. Chemical and Pharmaceutical Bulletin. 43(8). 1364–1378. 11 indexed citations

14.

MORIE, T., et al.. (1994). Synthesis and Biological Activities of the Optical Isomers of ( .+-. )-4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide (Mosapride).. Chemical and Pharmaceutical Bulletin. 42(4). 877–882. 20 indexed citations

15.

MORIE, T., Shiro Kato, Hiroshi Harada, et al.. (1994). Ring expansion of nitrogen-containing chloromethylheteroalicycles via aziridinium intermediates. Journal of the Chemical Society Perkin Transactions 1. 2565–2565. 17 indexed citations

16.

Kato, Shiro, T. MORIE, Hiroshi Harada, & Junichi Matsumoto. (1994). Asymmetric Synthesis of the Enantiomers of 2-Aminomethyl-4-(4-fluorobenzyl)morpholine, an Intermediate of Mosapride, a Gastroprokinetic Agent. Heterocycles. 38(5). 1033–1033. 2 indexed citations

17.

Kato, Shiro, T. MORIE, Naoyuki Yoshida, & Junichi Matsumoto. (1992). Novel Benzamides as Selective and Potent Gastrokinetic Agents. IV. Synthesis and Structure-Activity Relationships of 2-Substituted 4-Amino-N-((4-benzyl-2-morpholinyl)methyl)-5-chlorobenzamides.. Chemical and Pharmaceutical Bulletin. 40(6). 1470–1475. 3 indexed citations

18.

Kato, Shiro, et al.. (1992). Novel Benzamides as Selective and Potent Gastrokinetic Agents. III. Synthesis and Structure-Activity Relationships of 4-Amino-5-chloro-2-methoxy- and 2-Ethoxy-N-((4-substituted 2-morpholinyl)methyl)- benzamides.. Chemical and Pharmaceutical Bulletin. 40(3). 652–660. 7 indexed citations

19.

Kato, Shiro, T. MORIE, Tatsuya Kon, et al.. (1991). Novel benzamides as selective and potent gastrokinetic agents. 2. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide citrate (AS-4370) and related compounds. Journal of Medicinal Chemistry. 34(2). 616–624. 33 indexed citations

20.

Kato, Shiro, T. MORIE, Katsuhiko Hino, et al.. (1990). Novel benzamides as selective and potent gastric prokinetic agents. 1. Synthesis and structure-activity relationships of N-[(2-morpholinyl)alkyl]benzamides. Journal of Medicinal Chemistry. 33(5). 1406–1413. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact